FBI Investigating Unconfirmed Claims That Trump Was Personally Compromised by the Russians

Unsubstantiated allegations developed at the request of Democratic Party researchers that Donald Trump was compromised and in league with the Russians were presented to both President Obama and President-elect Trump in intelligence briefings last week. The FBI says it is investigating the allegations, which party operatives had delivered to the FBI and numerous news organizations before and since the election. The claims include allegations that Trump was personally compromised by the Russians and that Trump aides were involved in organizing the Russian hack of the Democratic Party. None of the allegations has been verified by ABC News, and some of them are provably false. A Trump lawyer named in the report forwarded to the FBI angrily denied any role in a supposed meeting with the Russians in Prague last August. “I’ve never been in Prague in my life,” said the lawyer, Michael Cohen. An FBI official said the allegations were too explosive and salacious not to be investigated.

Read more...
Positive 0 LOL 0 Interesting 0 Sad 0 Revolting 0 Fake 0

See also

2 men arrested 30 years after German teen death in N Ireland

Police in Northern Ireland have arrested two men in the death of a German backpacker 30 years ago, after much-publicized appeals on the anniversary of the teenager's death yielded a break in one of the region's most notorious unsolved murders

0 0

GLOBAL MARKETS-Stocks, oil and dollar rise as trade war put "on hold"

LONDON, May 21 (Reuters) - Stocks, oil prices and the dollar were on the rise on Monday after the U.S.-China trade war was declared "on hold" while in Europe, Italy's borrowing costs climbed and the Milan bourse retreated as two anti-establishment parties...

0 0

PRESS DIGEST-Canada-May 21

May 21 (Reuters) - The following are the top stories from selected Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

0 0

AstraZeneca potassium drug finally approved, threatening Vifor

LONDON, May 21 (Reuters) - The decision by U.S. regulators to finally approve AstraZeneca's much-delayed excess potassium drug Lokelma gives the group another new medicine launch, boosting its portfolio as it strives to offset declining sales of older pro...

0 0